Clinical trial
A Double-Blind, Placebo-Controlled Randomized Trial to Study the Viaskin Milk Efficacy and Safety for Treating IgE-Mediated Cow's Milk Allergy in Children
NCT02223182 is registered in ClinicalTrials.gov with DBV Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled Randomized Trial to Study the Viaskin Milk Efficacy and Safety for Treating IgE-Mediated Cow's Milk Allergy in Children
- Lead sponsor
- DBV Technologies
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- December 22, 2020
- Enrollment
- 198 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
food allergy